Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIVOLUMAB Cause Disease recurrence? 57 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Disease recurrence have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.

57
Reports of Disease recurrence with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
4
Deaths
24
Hospitalizations

How Dangerous Is Disease recurrence From NIVOLUMAB?

Of the 57 reports, 4 (7.0%) resulted in death, 24 (42.1%) required hospitalization, and 1 (1.8%) were considered life-threatening.

Is Disease recurrence Listed in the Official Label?

Yes, Disease recurrence is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.

What Other Side Effects Does NIVOLUMAB Cause?

Death (11,216) Malignant neoplasm progression (9,363) Off label use (5,208) Diarrhoea (4,692) Fatigue (3,709) Pyrexia (3,454) Intentional product use issue (3,297) Rash (2,816) Nausea (2,805) Decreased appetite (2,619)

What Other Drugs Cause Disease recurrence?

NIRMATRELVIR\RITONAVIR (20,040) PREDNISONE (1,979) CYCLOPHOSPHAMIDE (1,689) RITUXIMAB (1,588) METHOTREXATE (1,401) DOXORUBICIN (980) VINCRISTINE (932) PREDNISOLONE (873) MYCOPHENOLATE MOFETIL (852) DEXAMETHASONE (784)

Which NIVOLUMAB Alternatives Have Lower Disease recurrence Risk?

NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW NIVOLUMAB vs NIZATIDINE NIVOLUMAB vs NOMEGESTROL NIVOLUMAB vs NORDAZEPAM NIVOLUMAB vs NOREPINEPHRINE

Related Pages

NIVOLUMAB Full Profile All Disease recurrence Reports All Drugs Causing Disease recurrence NIVOLUMAB Demographics